Titles and Roles
- Professor and Vice Chair for Basic Research, Department of Hematology and Medical Oncology
- Emory University School of Medicine
- Interim Leader, Cancer Genetics and Epigenetics Research Program
- Winship Cancer Institute of Emory University
- Research Program
- Cancer Cell Biology
Lawrence Boise, PhD, is Professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine and serves as Interim Leader of the Cancer Genetics and Epigenetics Research Program at Winship Cancer Institute. Prior to joining Emory, Dr. Boise was at the University of Miami Miller School of Medicine where he was a professor in the Department of Microbiology and Immunology and director of that department's graduate program.
Dr. Boise earned his PhD in pharmacology at the Medical College of Virginia and did postgraduate training at the Howard Hughes Medical Institute at the University of Michigan and University of Chicago.
With longstanding funding by the National Cancer Institute as well as foundations such as the Multiple Myeloma Research Foundation and the TJ Martell Foundation, Dr. Boise's research team studies how therapeutic agents such as arsenicals and proteasome inhibitors work to kill myeloma cells.
Dr. Boise has published extensively in major peer-reviewed journals such as Blood, Molecular Cancer Therapeutics, Oncogene, and Molecular and Cellular Biology. He is on the editorial boards of the Journal of Biological Chemistry and Biochemical Journal and is a member of the NCI study section Cancer Molecular Pathobiology (CAMP). He also serves as a manuscript reviewer for numerous journals, including Nature Cancer Reviews and the Journal of Cell Biology.
Publications Publication Date
Dr. Boise has received the following select awards and honors:
- Mentoring Award, Emory University School of Medicine, 2017
- MilliPub Club, Emory University School of Medicine, 2015
- Multiple Myeloma Research Foundation Award